Page last updated: 2024-08-24

telmisartan and pd 98059

telmisartan has been researched along with pd 98059 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drexler, H; Fuchs, M; Grote, K; Hilfiker, A; Hilfiker-Kleiner, D; Kaminska, A; Kaminski, K; Kiian, I; Klein, G; Podewski, E; Wollert, KC1
Akiyoshi, Y; Miyamoto, S; Morishima, M; Ono, K; Wang, Y1

Other Studies

2 other study(ies) available for telmisartan and pd 98059

ArticleYear
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
    Circulation, 2004, May-11, Volume: 109, Issue:18

    Topics: Alkaloids; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Benzophenanthridines; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Flavonoids; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Naphthalenes; Neovascularization, Physiologic; Norepinephrine; Paracrine Communication; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Stress, Mechanical; Telmisartan; Tumor Necrosis Factor-alpha

2004
Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.
    European journal of pharmacology, 2009, May-01, Volume: 609, Issue:1-3

    Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Calcium Channels, T-Type; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; Extracellular Signal-Regulated MAP Kinases; F-Box Proteins; Flavonoids; Gene Expression Regulation; Heart Rate; Imidazoles; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Pyridines; Rats; Rats, Wistar; RNA, Messenger; Telmisartan; Tetrazoles; Time Factors; Valine; Valsartan; Zebrafish Proteins

2009